JPRN-UMIN000005017招募中2 期
A phase II study of Palonosetron combined with Dexamethasone and Aprepitant to prevent nausea and vomiting in patients receiving highly emetogenic chemotherapy for esophageal cancer - A phase II study of Palonosetron, Dexamethasone and Aprepitant in patients receiving chemotherapy for esophageal cancer
Yokohama City University Graduate School of Medicine0 个研究点目标入组 60 人开始时间: 2011年2月3日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) with seizure disorder needing anticonvulsants unless clinically stable 2) with vomiting, retching, or grade 2 or higher nausea according to CTCAE 3) with severe allergy to Palonosetron, Aprepitant and Dexamethasone 4) pregnant or nursing women or women who like be pregnant and men with partner willing to get pregnant 5) receiving an antiemetic drug 6) receiving pimozide (orap) 7) with history of mental disorder or treating it at the moment 8) doctor's decision not to be registered to this study
研究者
相似试验
已完成
不适用
A phase II study of palonosetron combined with dexamethasone to prevent nausea and vomiting induced by daily low-dose cisplatin-based concurrent chemoradiotherapy in patients with uterine cervical cancer.cervical cancerJPRN-UMIN000007638chiba university25
已完成
不适用
A phase II study of aprepitant, palonosetron, dexamethasone and olanzapine for the prevention of cisplatin-based hemotherapy-induced nausea and vomiting for thoracic malignancyThoracic malignancyJPRN-UMIN000017486Shizuoka cancer center30
已完成
不适用
A phase II trial of palonosetron and 1-day dexamethasone and 3-day aprepitant to prevent nausea and vomiting in patients receiving paclitaxel and carboplatipatients receiving paclitaxel and carboplatin for gynecologic malignanciesJPRN-UMIN000013082ara Medical University70
尚未招募
2 期
Randomized Phase II trial of Palonosetron/Dexamethasone concurrent therapy with prevention of CINV according to chemotherapy including Oxaliplatin or Irinotecan in patients with advanced colorectal cancer.JPRN-UMIN000005534ara Hospital Kinki University Faculty of Medicine80
尚未招募
不适用
Comparison Of Two Drugs For Prevention Of Post Operative Nausea Vomiting During Middle Ear SurgeryCTRI/2019/09/021157Department Of Anesthesiology And Critical Care